ALLISON CHRISTIAN: Open Payments
NPI 1285387548 · WINCHESTER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,725 in 81 payments from 27 companies in 2025. Trend: 2023 $2,794 · 2024 $2,240 · 2025 $1,725
Food & beverage: $1,725
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $200 |
| PFIZER INC. | 13 | $191 |
| Celgene Corporation | 5 | $161 |
| Daiichi Sankyo Inc. | 6 | $158 |
| AstraZeneca Pharmaceuticals LP | 6 | $156 |
| Incyte Corporation | 5 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $94 |
| Novartis Pharmaceuticals Corporation | 5 | $94 |
| Astellas Pharma US Inc | 3 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
Products named: REBLOZYL, JAKAFI, DATROWAY, CALQUENCE, KISQALI, TECVAYLI, RYBREVANT, ELREXFIO.
Industry payments across KY — which companies pay providers there.
